Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision v3.3.2 was added to the study record history and the previous revision v3.3.1 was removed.
    Difference
    0.1%
    Check dated 2025-11-30T10:32:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The history now shows a new revision entry, v3.3.1. The prior revision, v3.2.0, has been removed.
    Difference
    0.1%
    Check dated 2025-11-23T08:13:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and related update delays was removed from the page.
    Difference
    0.7%
    Check dated 2025-11-16T06:06:01.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Version 2025-05-27 was added to the Record History, reflecting an updated Study Status for NCT03667170. This entry provides the latest status information for the trial.
    Difference
    0.1%
    Check dated 2025-11-02T00:36:24.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Updated page to v3.2.0 with a prominent operating-status notice; removed previous v3.1.0.”
    Difference
    13%
    Check dated 2025-10-04T12:11:09.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    - Version updated from v3.0.2 to v3.1.0. This indicates a new release/build; no other content changes are indicated.
    Difference
    0.3%
    Check dated 2025-09-27T07:28:25.000Z thumbnail image

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.